Vitamin A Corrects Tissue Deficits in Diet-Induced Obese Mice and Reduces Influenza Infection After Vaccination and Challenge.
Journal
Obesity (Silver Spring, Md.)
ISSN: 1930-739X
Titre abrégé: Obesity (Silver Spring)
Pays: United States
ID NLM: 101264860
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
28
04
2020
revised:
24
05
2020
accepted:
26
05
2020
pubmed:
12
8
2020
medline:
13
4
2021
entrez:
12
8
2020
Statut:
ppublish
Résumé
Individuals with obesity suffer from an increased susceptibility to severe respiratory viral infections and respond poorly to vaccinations, making it imperative to identify interventions. Recent evidence suggesting that obesity leads to tissue-specific vitamin A deficiency led to an investigation of whether high-dose oral vitamin A, a treatment used for remediating vitamin A deficiency in developing countries, could correct obesity-associated tissue deficits. Adult C57BL/6 diet-induced obese mice were supplemented with vitamin A for 4 weeks. A subset of mice were then vaccinated with inactivated influenza virus and challenged. Following supplementation, tissue vitamin A levels, lung immune cell composition, blood inflammatory cytokines, antibody responses, and viral clearance were evaluated. Supplementation significantly improved vitamin A levels in lung and adipose tissues in diet-induced obese mice. Additionally, supplementation decreased inflammatory cytokines in the blood and altered the lung immune environment. Importantly, vaccinated, vitamin A-treated diet-induced obese mice exhibited improved antibody responses and significantly reduced viral loads post challenge compared with PBS-treated mice. Results demonstrate a low-cost intervention that may correct vitamin A tissue deficits and help control respiratory viral infections in individuals with obesity.
Identifiants
pubmed: 32779401
doi: 10.1002/oby.22929
pmc: PMC7483416
mid: NIHMS1600508
doi:
Substances chimiques
Vitamin A
11103-57-4
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1631-1636Subventions
Organisme : NICHD NIH HHS
ID : R01 HD066982
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA021765
Pays : United States
Organisme : NIAID NIH HHS
ID : 75N93019C00052
Pays : United States
Informations de copyright
© 2020 The Obesity Society.
Références
Int J Obes (Lond). 2012 Aug;36(8):1072-7
pubmed: 22024641
J Neurosci. 2016 May 4;36(18):5170-80
pubmed: 27147667
Vaccine. 2015 Aug 26;33(36):4422-9
pubmed: 26163925
J Infect Dis. 1993 May;167(5):1003-7
pubmed: 8486934
J Nutr. 1993 Apr;123(4):634-41
pubmed: 8463864
Sci Rep. 2015 Nov 02;5:15893
pubmed: 26522079
Obesity (Silver Spring). 2020 May;28(5):847
pubmed: 32237212
Influenza Other Respir Viruses. 2014 Jan;8(1):25-32
pubmed: 23957732
Int J Obes (Lond). 2017 Sep;41(9):1324-1330
pubmed: 28584297
Am J Respir Cell Mol Biol. 2017 Jul;57(1):66-76
pubmed: 28257233
J Pediatr. 2017 Aug;187:323-327
pubmed: 28578159
Clin Vaccine Immunol. 2012 May;19(5):757-65
pubmed: 22398245
Clin Vaccine Immunol. 2016 Jan 06;23(3):219-27
pubmed: 26740391
PLoS One. 2018 Oct 31;13(10):e0205747
pubmed: 30379862
Vaccine. 2014 May 7;32(22):2521-4
pubmed: 24657715
J Infect Dis. 2018 Sep 22;218(9):1378-1382
pubmed: 30085119
Nat Rev Immunol. 2008 Sep;8(9):685-98
pubmed: 19172691
Viruses. 2019 Sep 30;11(10):
pubmed: 31575021
Proc Nutr Soc. 2012 May;71(2):290-7
pubmed: 22369848
PLoS One. 2010 Mar 15;5(3):e9694
pubmed: 20300571